Medicines Adverse Reactions Committee
The Medicines Adverse Reactions Committee (MARC) is a technical advisory committee established under section 8 of the Medicines Act 1981 to advise the Minister of Health on the safety of approved medicines.
The MARC comprises up to 11 members, with any of the following:
- substantial clinical experience and national credibility in one or more of the following: clinical pharmacology, general medicine, paediatrics, general practice and other medical specialties e.g. cardiology;
- a tertiary qualification and extensive experience in epidemiology;
- a tertiary qualification and extensive experience in clinical pharmacy; or
- experience in representing consumer interests.
The MARC also includes one representative each from Medsafe and the New Zealand Pharmacovigilance Centre.
Members are appointed for a three year term, which may be renewed once for a further three years.
The MARC meets four times a year in Wellington and generally for a full day. Secretarial support is provided by Medsafe.
For further information about the MARC, please contact Medsafe on (04) 819 6800 and ask to be put through to the MARC Secretary.
Terms of reference of the MARC